EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases

Yiming Zhang, Yesi Shi, Muhammad M Khan, Fan Xiao, Wei Chen, Wei Tao, Ke Yao, Na Kong

Trends in Biotechnology · 2024-11 · 42 (11) · 1439-1452

DOI: 10.1016/j.tibtech.2024.05.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Biotechnology, 2024-11. Verfasst von Yiming Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Liangzhu Laboratory, Zhejiang University Medical Center and Zhejiang Provincial Key Lab of Ophthalmology, Eye Center of The Second Affiliated Hospita…. Hauptthemen laut MEDLINE: Eye Diseases, Nanomedicine, RNA. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 96 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocular disorders remain a major global health challenge with unmet medical needs. RNA nanomedicine has shown significant therapeutic benefits and safety profiles in patients with complex eye disorders, already benefiting numerous patients with gene-related eye disorders. The effective delivery of RNA to the unique structure of the eye is challenging owing to RNA instability, off-target effects, and ocular physiological barriers. Specifically tailored RNA medication, coupled with sophisticated engineered delivery platforms, is crucial to guide and advance developments in treatments for oculopathy. Herein we review recent advances in RNA-based nanomedicine, innovative delivery strategies, and current clinical progress and present challenges in ocular disease therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eye DiseasesNanomedicineRNAHumansAnimalsDrug Delivery SystemsGenetic Therapy

Stichwörter der Autor:innen

RNA nanomedicinenanocarriersocular barriersocular diseaseocular drug delivery

Substanzen

RNA

Autor:innen und Institutionen

  • Liangzhu Laboratory, Zhejiang University Medical Center and Zhejiang Provincial Key Lab of Ophthalmology, Eye Center of The Second Affiliated Hospital, Zhejiang University, Hangzhou, China; Center for Nanomedicine and D…
  • Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: wtao@bwh.harvard.edu.
  • Liangzhu Laboratory, Zhejiang University Medical Center and Zhejiang Provincial Key Lab of Ophthalmology, Eye Center of The Second Affiliated Hospital, Zhejiang University, Hangzhou, China. Electronic address: xlren@zju…

Zitieren

APA

Zhang, Y., Shi, Y., Khan, M. M., Xiao, F., Chen, W., Tao, W., Yao, K., & Kong, N. (2024). Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases. Trends in Biotechnology, 42(11), 1439-1452. https://doi.org/10.1016/j.tibtech.2024.05.002

Vancouver

Zhang Y, Shi Y, Khan MM, Xiao F, Chen W, Tao W, et al. Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases. Trends in Biotechnology. 2024;42(11):1439-1452. doi:10.1016/j.tibtech.2024.05.002

BibTeX
@article{Zhang2024,
  author = {Zhang, Yiming and Shi, Yesi and Khan, Muhammad M and Xiao, Fan and Chen, Wei and Tao, Wei and Yao, Ke and Kong, Na},
  title = {Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases},
  journal = {Trends in Biotechnology},
  year = {2024},
  volume = {42},
  number = {11},
  pages = {1439--1452},
  doi = {10.1016/j.tibtech.2024.05.002}
}
Kostenlos starten →